this disorder. Hypoglycaemia, a feature of 9 of the above 22 cases, was not a symptom and a fasting pretreatment plasma glucose was normal in the present patient.
Multiple paragangliomata secreting catecholamines and calcitonin with intermittent hypercalcaemia 1 MCWhite MB MRCP 2 B R Hickson MB MRCP St Bartholomew's Hospital, London £1
A patient is described who presented with transient cerebral ischaemic attacks and paroxysmal hypertension. He was found to have bilateral carotid body tumours, an extra-adrenal paraganglioma, an adjacent ganglioneuroma and abnormally high venous levels of catecholamines (predominantly noradrenaline) and calcitonin. No medullary carcinoma of the thyroid was discovered but the extra-adrenal paraganglioma was found to contain considerable quantities of calcitonin and noradrenaline and probably secreted both hormones. The significance of this case is discussed. History A 41-year-old white male was admitted to hospital in March 1975 after suffering three transient cerebral ischaemic episodes affecting his right face and limbs with both motor and ensory deficit. He reported that his father had a pulsatile lump in the side of his neck, which ad been present for many years and for which he had refused investigations. . On admission there were no residual neurological signs following an observed transient lschaemic episode during which his blood pressure was 160/105 mmHg. He was in sinus r~Ythm at a rate of 76 per minute. There were no bruits audible but he had a slight swelling of e left side of his neck. While awaiting carotid angiograms he was asymptomatic but :termittently hypertensive with a diastolic blood pressure reaching a maximum of 115 mmHg.
Ilateral carotid angiograms revealed a left carotid body tumour which was impinging on the
POste~i or
wall of the left internal carotid artery, just distal to the bifurcation, and the right carotId angiogram was reported as normal, as was the intracranial circulation. The patient was referred for surgery. li~wenty-four hour urinary vanillylmandelic acid (VMA) estimations were within n?rmal ml ts;
an oral 50 g glucose tolerance test was marginally diabetic (blood sugars at 0 mmutes . mmol/l, 30 minutes 7.3 mmol/l, 60 minutes 10.5 mmol/l, 90 minutes 10.5 mmol/l, 120
(lOutes 9.0 mmol/l}; and two serum calcium levels were elevated (2.65 mmol/l, 2.75 mmol/l) normal range 2.10-2.60 mmol/l). At surgery a tumour was encroaching on the common carotid. artery at the bifurcation. The lymph nodes superficial to the carotid arteries were enlarged and removed for biopsy. The internal jugular vein was infiltrated by tumour, and the removal of the common carotid artery and internal jugular vein was necessary. he tumour was reported histologically as a carotid body tumour with no increase in mitotic aCb.vity ( Figure I ) and the nodes showed a reactive hyperplasia only. During surgery the pa~l ent developed a sinus tachycardia and hypertension. Postoperatively he had several episodes of transient hypertension associated with sweating and severe occipital headache, and fUrther investigations were then undertaken to exclude a phaeochromocytoma. Plasma C~techolamines were elevated (adrenaline 3.17 nmol/l, normal range < 2.7 nmol/l; noradren-alIne 11.25 nmol/l, normal range <6.5 nmol/l) with predominantly increased levels of noradrenaline. Urinary VMA levels were now marginally elevated (50-60 Jlmol/24 h, normal range < 35 Jlmol/24 h). He was admitted for venous catheter sampling to locate any area of high catecholamine production.
Three main sites of increased catecholamine activity were found (Table 1) : in the right internal jugular vein, the left thymic vein and the left renal vein. Subsequent arch aortography confirmed a tumour circulation in the region of the right carotid body -missed at previous carotid angiography -and left extra-adrenal tumour circulation in the loin. Tomography of the anterior mediastinum showed a possible mass but this was not confirmed by computerized axial tomography scanning. Peripheral blood for immunoreactive parathyroid hormone (PTH) and calcitonin levels was taken at this time and showed a normal PTH level but a raised level of calcitonin at 20 Jlg/l (normal range <0.08 Jlg/l). Pertechnate scans of the thyroid showed no abnormality.
In January 1976, at exploratory laparotomy, two para-adrenal tumours were removed. The first, a paraganglioma 4 x 3 em, appeared to arise anteriorly from the lower aspect of the left adrenal gland but was separate from and infiltrating the adrenal cortex ( Figure 2 ). Adjacent to the posterior aspect of the gland was an encapsulated 6 x 3 em tumour, histologically a ganglioneuroma. The paraganglioma was assayed for PTH, catecholamines and calcitonin (Table 2) . Postoperatively the patient made an excellent recovery and had no further episodes of paroxysmal hypertension. In February 1977, the patient developed hypertension and this has persisted with a diastolic blood pressure of 100 mmHg. Urinary VMA levels have been marginally elevated « 44 Jlmol/24 h) and a further selective venous catheterization was undertaken revealing increased noradrenaline levels in the left thymic vein but not from the right internal jugular vein draining a known site of a previously demonstrable functioning Normal levels : noradrenaline, < 6.5 nmol/l; adrenaline, < 2.7 nrnol/l: total catecholamines, < 9.0 nmol/l paraganglioma. Serum calciums and plasma calcitonin levels have been consistently normal (Table 3) .
Methods
Catecholamines were measured in the plasma by the method of Wood & Mainwaring-Burton (1975) using a fully-automated technique. Calcitonin M was measured in the plasma using a radioimmunoassay technique described by Clark et al. (I969) . Venous catheter sampling was undertaken under alpha and beta blockade (Ross et al. 1967) .Phenoxybenzamine 1 mg/kg was infused intravenously in 250 ml of 5% dextrose over 1 hour for three consecutive days prior to venous catheterization. Propranolol 40 mg twice daily was given on the second and third days. The inferior vena cava was catheterized via the right femoral vein using the Seldinger technique. The catheter was advanced under direct vision into selected sites (Table 1) , from which blood was withdrawn into labelled tubes containing lithium heparin. Samples were immediately separated in a refrigerated centrifuge and stored in stoppered tubes on dry ice, being kept at -20°C until assayed within 7 days of collection. Immunoreactive parathyroid hormone (PTH) was measured using a modified radioimmunoassay method described by Greenberg et al. (1974) .
Histology
The tumour in the neck is vascular with an organoid pattern. Cells are small, with eosinophilic cytoplasm and rounded nuclei in the centre of the nests, and with oval nuclei and scanty cytoplasm surrounding each cluster. There is no increase in mitotic activity and little atypicality. The features are those of a typical carotid body tumour (Figure 1) . The left extraadrenal tumour (Figure 2) is well defined but not encapsulated, and is a richly cellular tumour. Cells are small with ovoid to polyhedral nuclei, and show moderate pleomorphism. There are no mitotic figures evident. The posterior surface of the tumour was intimately mixed with many immature ganglion cells of a sympathetic ganglion. Morphologically the tumour would seem to be a paraganglioma and is possibly a hybrid, being unlike a classical phaeochromocytoma of the adrenal medulla but bearing a strong resemblance to the carotid body tumour.
Discussion
The paraganglion system derives from histologically similar nests of cells from the neural crest, scattered throughout the body, and includes all chemoreceptor tissue (Shamblin et al. 1971 ).
Carotid, ciliary, jugular, vagal, pulmonary, coronary, aortic, para-adrenal and bladder paraganglia are all recognized (Glenner & Grimley 1974) in addition to the adrenal medulla. Classically, adrenal medullary tumours are referred to as phaeochromocytomas. Paragangliomata secreting catecholamines and clinically presenting as phaeochrom ocytomas are well recognized (McMillan 1956 , Berdal et al. 1962 , Glenner et al. 1962 ) and subsequently have been described from many sites (Glenner & Grimley 1974) . Multiple secreting paragangliomata have been less frequently reported (Duke et al. 1965 , Maier & Humphreys 1958 ) and malignant secreting tumours are even rarer (Hamberger et af. 1967 , Clinicopathological Conference 1976 .
The rarity of multiple functioning paragangliomata in the literature may reflect the lack of investigations undertaken to exclude such tumours, but also reflects a difficulty of precise terminology amongst authors. There is no doubt that some extra-adrenal paragangliomata are reported as phaeochromocytomas (Sato et al. 1974 , Cone 1958 . It is also apparent from case reports in the literature that the persistence of symptoms after a known phaeochromocytom a has been removed is most likely to be due to an extra-adrenal functional paragangliomata (Steiner et al. 1968 , Cone 1958 , Marks & Channick 1974 . This suggests that the incidence of these tumours is possibly higher than the figures usually quoted of between 10-15% of phaeochromocytoma series (Remine et al. 1974 , Steiner et al. 1968 ) and emphasizes that one cannot be sure when investigating patients with a suspected phaeochromocytoma that there is not more than one source of catecholamine production.
There are several reasons why the knowledge of the presence of functioning paragangliomata is important. First, it is possible that there may be an increased incidence of metastatic tumour development if these tumours are left in situ. There are insufficient figures available on secreting paragangliomata themselves, but the incidence of malignancy in carotid body tumours (a paraganglioma in the neck) may be as high as 23% providing the follow up is long enough (Martin et al. 1973) ; retroperitoneal paragangliomata have a high metastatic incidence (Olson & Abell 1969) ; and the mortality from malignant extra-adrenal tumours which have been removed is 28.6% at two years (Remine et al. 1974). In practical terms it may not always be safe to remove a known functioning paraganglioma due to its anatomical situation, but at least that decision can be made early and close follow up may determine when the tumour must be removed either because of local compressive symptoms or malignant change. It has been suggested that malignancy in such tumours may be detected as they secrete dopamine preferentially to other catecholamines and therefore urinary homovanilic acid levels will be elevated (Robinson et af. 1976 ). In any case, patients who have functioning paragangliomata will require life long follow up since further lesions, even if not suspected initially, may present with or without symptoms of hypertension over a long period of time (Maier & Humphreys 1958 , Revak et al. 1971 , Marks & Channick 1974 . Noting our case history, it is possible that such lesions have in fact been present all the time but their functional activity may be variable and take considerable time before becoming clinically apparent, and their initial size may be so small that they are not noticed by conventional investigations.
Thirdly, it is possible that hypertension persisting after removal of phaeochromocytomas (26% in the series of Remine et al. 1974) is not always due to irreversible renal damage but to the persistence of undiscovered but functioning paragangliomata; this would seem to be the case in our patient whose VMA levels are only just elevated beyond the normal range, whose renal function is still biochemically normal, and who has none of the paroxysmal symptoms that made the initial diagnosis of a phaeochromocytoma so probable.
There are certain features which may help to distinguish extra-adrenal from adrenal medullary tumours. First, secreting paragangliomata of the carotid body, glomus jugulare, or bladder may each present with symptoms specific to their anatomical site. Secondly, children are more likely to have extra-adrenal tumour's than adults (Hume 1960) , and biochemical investigations will reveal a high plasma ratio of noradrenaline to adrenaline in paragangliomata, as cortisol is essential for enzymic conversion of noradrenaline to adrenaline (Wurtman 1966) . Thus it is only the adrenal medulla which predominantly secretes adrenaline.
When phaeochromocytomas metastasize, the metastases behave more like paragangliomata secreting noradrenaline or dopamine. . At present, selective venous sampling for catecholamines is probably the most useful nvestigation in looking for secretory paragangliomata. However, it may not always be helpful In localizing tumours and certainly not those that are functionless at the time of the study, as is clear from the second catheterization in our patient whose known functional right carotid body tumour was not active and therefore went undetected.
Hypercalcaemia has been previously described with phaeochromocytoma but the mechanism has been disputed. Activation of adenyl cyclase release of PTH by catecholamines (K.ukreja et al. 1973 (K.ukreja et al. , Bouillon et al. 1974 , direct catecholamine effect on skeletal cyclic adenosine monophosphate (Finlayson & Casey 1975) ,inappropriate PTH secretion (Swinton et al. 1972) , and a prostaglandin stimulation of calcium metabolism have all been postulated, while there are some patients with phaeochromocytomas who have parathyroid adenomata separately as part of a multiple endocrine neoplasia syndrome (MEA II) (Miller et al. 1975 , Steiner et al. 1968 ). In our case, no immunoassayable PTH was found in the paragauglk'••~a removed or in the peripheral or adrenal veins pre-and postoperatively. This does not exclude the presence of a nonimmunoreactive but biologically active PTH-like substance in the Paraganglioma or in the ganglioneuroma, which was not assayed.
Elevated calcitonin levels have been found in a case of phaeochromocytoma without medullary carcinoma of the thyroid (Milhaud et al. 1974) ,and recently isolated from an intraadrenal phaeochromocytoma in small quantities (Kalager et al. 1977) .The hormone has also been isolated from mucosal neuromas in a patient who did have coexistent medullary carcinoma of the thyroid, but in whom it seemed there was separate secretion of the hormonẽ rom these lesions (Voelkel et al. 1973) .Immunoreactive calcitonin has also been demonstrated ill patients with a variety of nonthyroid tumours (Silva et al. 1973 , Coombes et al. 1974 , Commonly carcinoma of the bronchus and breast. It would also seem to occur normally in adrenal glands (Kaplan et al. 1969) . It is not, therefore, surprising to find this hormone in a paraganglioma, although to our knowledge this has not been reported before, The associated presence of both calcitonin and noradrenaline in the same paraganglioma suggests a more than casual relationship and supports the increasingly accepted view of APUD tumours and the migration of neural crest cells which function endocrinologically (Pearse & Welbourn 1973) . . Although predominantly elevated adrenaline levels are highly suggestive of an adrenal illtramedullary tumour, and noradrenaline an extra-adrenal tumour, one cannot be certain Whether there will be single or multiple secreting tumours in any particular case, and past eports of hormone secreting paragangliomata have not adequately indicated the true illcidence of these tumours or their behaviour pattern compared with intramedullary phaeochromocytomas.
We feel that the term phaeochromocytoma should be reserved for adrenal intramedullary tUmours only, and that all other catecholamine-secreting tumours of the paraganglion system should be called paragangliomata with their anatomical site added for extra information. It is sensible that cases which have been investigated for suspected phaeochromocytoma and who have elevated plasma catecholamines should undergo selective venous catheterization and have catecholamines measured from sites where paraganglia occur. Furthermore, an elevated al ci toni n level in association with paragangliomata or phaeochromocytomas does not Invariably presuppose the presence of a medullary carcinoma of the thyroid, and we suggest th.atWhere there is doubt venous sampling for this hormone can be undertaken simultaneously With that for catecholamines. PTH should also be assayed when hypercalcaemia is present. Tumours removed at surgery should be assayed for their 'hormone content, and if possible for all those hormones which one might expect to be present in neural crest cell tumours (Tischler t al. 1977) . The case presented here would seem to be unique, but one might expect an lllcreasing number of similar cases now that our understanding of the paraganglion system and neural crest tumours in general is clearer. Paragangliomata secreting catecholamines and Causinghypertension are probably not asrare as one might suppose from the current literature.
